Ms. Mikail serves as our executive vice president of corporate development, general counsel, and secretary. Prior to joining Dendreon, Ms. Mikail served as senior vice president, corporate development at Savient Pharmaceuticals, Inc. Prior to that, Ms. Mikail served as vice president, general counsel and secretary for ImClone Systems, Inc., a wholly-owned subsidiary of Eli Lilly & Company, as well as a member of Eli Lilly’s Transactions Center of Expertise. Previously, Ms. Mikail worked at the law firms of Reed Smith LLP, Lowenstein Sandler PC and Wilmer Hale. Ms. Mikail earned her Bachelor of Arts from Rutgers University and J.D. from Fordham University School of Law.